Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation - Wikidata - wikimedia - TriplyDB

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

http://www.wikidata.org/entity/Q35887767

about

Physiological stress-induced corticosterone increases heme uptake via KLF4-HCP1 signaling pathway in hippocampus neurons.Krüpple-like factors in the central nervous system: novel mediators in stroke.Dual RNA sequencing reveals the expression of unique transcriptomic signatures in lipopolysaccharide-induced BV-2 microglial cells.Transcriptome sequencing of microglial cells stimulated with TLR3 and TLR4 ligands.Systemic inflammation and microglial activation: systematic review of animal experiments Total Syntheses and Biological Evaluation of (±)-Botryosphaeridione, (±)-Pleodendione, 4-epi-Periconianone B, and Analogues.HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis.PPAR agonists as therapeutics for CNS trauma and neurological diseases Vespa tropica venom suppresses lipopolysaccharide-mediated secretion of pro-inflammatory cyto-chemokines by abrogating nuclear factor-κ B activation in microglia.Interleukin-1β orchestrates underlying inflammatory responses in microglia via Krüppel-like factor 4.Induction of KLF4 contributes to the neurotoxicity of MPP + in M17 cells: a new implication in Parkinson's disease.Fenugreek Seed Powder Attenuated Aluminum Chloride-Induced Tau Pathology, Oxidative Stress, and Inflammation in a Rat Model of Alzheimer's Disease.Induction of Krüppel-like factor 4 expression in reactive astrocytes following ischemic injury in vitro and in vivo.Fisetin enhances behavioral performances and attenuates reactive gliosis and inflammation during aluminum chloride-induced neurotoxicity.Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling.Botanical Polyphenols Mitigate Microglial Activation and Microglia-Induced Neurotoxicity: Role of Cytosolic Phospholipase A2.Glial responses during epileptogenesis in Mus musculus point to potential therapeutic targets

P2860

Q33916127-DE0FB266-6B76-4815-BCF7-452CA2C07FC8 Q33962267-00E0462A-D200-4A13-B456-349CD9614B44 Q35219466-213BAE78-7C99-4D42-8A4A-9ACE6DC1F7BA Q35687371-50E0B7C6-532A-4BF1-A6C7-28FAFB944F93 Q35750202-0A797D65-5E21-4DEB-AA2E-5F2FD5C04C76 Q36281026-51BD1023-2C45-4C82-A0E8-1209D4B4B26F Q36529679-0C17AAAC-4525-4F4A-B717-2CA8BE46470C Q37400355-07D374EA-1EB3-4558-B07B-C4105127DF8E Q39000204-8C986E4B-6328-4AE0-81A6-C6172A28D9D5 Q39118762-6605450F-0440-4F09-8578-56E564B1C7B9 Q39201271-AFAB64C2-12D6-47CC-B0BB-DC844280A8A7 Q40066428-D966B92D-385B-44C0-B394-09304BFD6F7D Q45069805-15941B4C-6789-4B8C-B51F-7A860462C412 Q47924987-2FB1D5D4-7D29-4319-9D02-EE8961828B0A Q48181933-9176FF21-F079-4DFF-BBE9-A9B36E6D6780 Q48187537-EB582E8A-7D5E-42FB-8F76-9C0D432AF6B3 Q58775273-D699A96E-6C26-4DD2-B47F-1A6AC39AD249

P2860

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

http://www.wikidata.org/entity/Q35887767

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@ast

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@en

type

label

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@ast

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@en

prefLabel

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@ast

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@en

P1433

Q35887767-134976A9-8E32-45DA-8839-33EC7C69E598

P1476

Q35887767-124C6DF4-271E-4099-8468-3B29590498F8

P2093

Q35887767-152D2EC1-9D32-43CD-8E50-9F46713B6DEC

Q35887767-181B31C0-0A8A-48E7-BF7C-072ED664718D

Q35887767-3C0EBDAA-1B02-40D2-A954-1B5E171C14CB

Q35887767-A750CE5B-DE52-4F4E-B33D-4CC2BB350C23

P2860

Q35887767-0079A3EA-6233-41AE-B8D2-0E9CBCD3FCB8

Q35887767-059AAF33-EC2D-47E0-979C-FD2434B98BCE

Q35887767-093DF356-3312-4E02-A727-D3C6038B641E

Q35887767-0B66A133-EC41-48E6-BD9D-4B002F937845

Q35887767-0BEB5851-EA6B-43F3-9729-B4F21145BFA0

Q35887767-1417B1F7-B653-4599-BF87-003581D8AD44

Q35887767-2410A35E-267F-4489-B812-8BBB012FFB2A

Q35887767-29ECF0A7-4788-462F-996C-1AAA32D55A7F

Q35887767-34A316DE-B1B9-4C6A-B863-66618AF0084F

Q35887767-35B92063-6ED7-4CB7-A6ED-D08108E01771

P2888

Q35887767-EE15EC0B-9042-4DC9-A9A7-4B0E8608BA53

P304

Q35887767-8D5E82E1-3D53-4F66-8EC2-FB96CC6564AD

P31

Q35887767-4F88D5D5-30B3-45FA-B17A-4629C5A8A88B

P356

Q35887767-CF6DB057-0C06-4D0D-8048-0D1A4A023B9D

P478

Q35887767-CB463F31-D29E-4884-9085-D0EFED540DBD

P50

Q35887767-03AAE085-07A2-49F5-A9CC-43D550B42952

P577

Q35887767-6088EF39-3133-413C-B469-21FDF615FC2F

P5875

Q35887767-692260CA-BD08-4383-B0EF-97F1FA015E66

P6179

Q35887767-93100E0D-AB5A-4DC8-9BB2-D77AF26D7055

P698

Q35887767-0910C504-F66A-4362-A6FE-999485C29E4E

P921

Q35887767-4778322A-C9F1-469D-AF18-7E8C6C65B02A

P932

Q35887767-42B50254-A0A3-4C87-A405-9451F5D617FD

P356

P1433

Journal of Neuroinflammation

P1476

Therapeutic targeting of Krüppel-like factor 4 abrogates microglial activation

@en

P2093

Deepak Kumar Kaushik

http://www.w3.org/2001/XMLSchema#string

Kanhaiya Lal Kumawat

http://www.w3.org/2001/XMLSchema#string

Malvika Gupta

http://www.w3.org/2001/XMLSchema#string

Rupanjan Mukhopadhyay

http://www.w3.org/2001/XMLSchema#string

P2860

Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model

Inhibitory effects of honokiol on lipopolysaccharide-induced cellular responses and signaling events in human renal mesangial cells

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

Honokiol, a multifunctional antiangiogenic and antitumor agent

Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage

Klf4 is a transcription factor required for establishing the barrier function of the skin

Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase

Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production

Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage

Anti-inflammatory bioactivities of honokiol through inhibition of protein kinase C, mitogen-activated protein kinase, and the NF-kappaB pathway to reduce LPS-induced TNFalpha and NO expression

P2888

P304

57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-2094-9-57

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221722152

http://www.w3.org/2001/XMLSchema#string

P6179

1051422497

http://www.w3.org/2001/XMLSchema#string

P698

22429472

http://www.w3.org/2001/XMLSchema#string

P921

P932

3325890

http://www.w3.org/2001/XMLSchema#string